You are viewing the site in preview mode
Skip to main content
|
Gene
|
Coding variants
|
In silico predictions
| |
|
AlignGVGD
|
PolyPhen2
|
SIFT
|
MutPred
|
SNPs&GO
|
PhD-SNP
|
SNAP
|
Consensusa
|
|
MLH1
|
c.1913G > T (G638 L)
|
C15
|
Probably damaging
|
Deleterious
|
Benign
|
Neutral
|
Neutral
|
Neutral
|
B (3/7)
|
|
c.1919C > T (P640L)
|
C65
|
Probably damaging
|
Deleterious
|
Deleterious
|
Disease
|
Disease
|
Disease
|
LP (7/7)
|
|
MSH2
|
c.944G > T (G315 V)
|
C0
|
Benign
|
Deleterious
|
Benign
|
Neutral
|
Neutral
|
Neutral
|
B (1/7)
|
|
c.1074G > C (E358D)
|
C35
|
Possibly damaging
|
Tolerated
|
Benign
|
Neutral
|
Disease
|
Neutral
|
B (3/7)
|
|
c.2120G > A (C707Y)
|
C0
|
Probably damaging
|
Damaging
|
Benign
|
Disease
|
Disease
|
Disease
|
LP (5/7)
|
|
MSH6
|
c.3151G > A (V1051I)
|
C0
|
Benign
|
Tolerated
|
Benign
|
Neutral
|
Neutral
|
Neutral
|
B (0/7)
|
|
Noncoding variants
|
Splice-site predictions
| |
|
SpliceSiteFinder-like
|
MaxEntScan
|
NNSPLICE
|
GeneSplicer
|
HumanSpliceSite Finder
|
Consensusb, c
|
|
MLH1
|
c.116 + 3A > T
|
D (75.7 → 0)
|
D (8.6 → 2.4)
|
D (0.9 → 0)
|
D (5.5 → 0)
|
NE
|
LP (4/5)
|
|
c.116 + 4C > A
|
NE
|
NE
|
NE
|
NE
|
NE
|
B (0/5)
|
|
c.1990-26 T > C
|
NE
|
NE
|
NE
|
NE
|
NE
|
B (0/5)
|
|
MSH2
|
c.2006-36_2006-33dup
|
NE
|
NE
|
NE
|
NE
|
NE
|
B (0/5)
|
|
MSH6
|
c.457 + 50 T > A
|
NE
|
NE
|
NE
|
NE
|
NE
|
B (0/5)
|
|
c.3556 + 170del
|
NE
|
NE
|
NE
|
NE
|
NE
|
B (0/5)
|
|
c.4001 + 26A > G
|
NE
|
D (0 → 2.9)
|
NE
|
NE
|
D (0 → 71.4)
|
B (2/5)
|
- B Benign, D Donor, LP Likely pathogenic, NE No effect
- aThe variant is considered as likely pathogenic by five of the seven protein function prediction algorithms
- b The variant is considered as likely pathogenic by four of the five splice-site prediction algorithms
- c > 20% change in score (i.e., a wild-type splice-site score decreases and/or a cryptic splice-site score increases) is considered as significant